Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2025 04:00 ET | Source: AKAMPION

Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas

Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging clinical activity in heavily pre-treated patients including meaningful...
May 12, 2025 04:00 ET | Source: AKAMPION

Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate

ODD granted for the treatment of soft tissue sarcomas (STS)Thermosome adds 4 patents to its growing patent estate Munich, Germany – May 12, 2025 – Thermosome, a drug development company focused on...
December 04, 2024 04:00 ET | Source: AKAMPION

Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001

Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to ﬁnal dose level 3 Munich, Germany – December 4, 2024 – Thermosome, a drug development company...
November 19, 2024 04:00 ET | Source: AKAMPION

Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 Munich,...
June 11, 2024 04:00 ET | Source: AKAMPION

Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer

- Experienced biopharma professional focused on drug product development Munich, Germany - June 11, 2024 - Thermosome, a drug development company focused on targeted tumor therapies, today...
February 06, 2024 04:00 ET | Source: AKAMPION

Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001

- First dose level rated as safe by independent Data Safety Monitoring Board- Second dose level to be administered according to plan- THE001 designed as targeted tumor treatment independent...
December 05, 2023 04:00 ET | Source: AKAMPION

Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board

- Two renowned oncology experts to support the development of Thermosome's clinical candidate THE001 Munich, Germany – December 05, 2023 – Thermosome, a drug development company specializing...